© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, STAAR Surgical Company (STAA) shows an Average True Range (ATR) of 1.57 and an Enterprise Value of 2.19B. Its average trading volume over the past 3 months is 1.16M, indicating liquidity. These fundamental metrics provide insight into STAA's underlying financial health and market activity.
STAAR Surgical Company (STAA) technical indicators as of December 22, 2025: the SMA 20 is -1.15%, SMA 50 at -3.07%, and SMA 200 at 14.06%. The RSI 14 value is 48.87, suggesting its current momentum. These technical analysis signals help assess STAA's price trends and potential future movements.
STAAR Surgical Company (STAA) stock performance overview as of December 22, 2025: The 52-week high is $30.81 (currently -18.4% below), and the 52-week low is $13.5 (currently 86.22% above). Over the past year, STAA's performance is 1.13%, compared to the S&P 500's 12.87% change.
According to market data, STAAR Surgical Company (STAA) stock's recent performance metrics show that over the last month, STAA is -2.06%, with a Year-to-Date (YTD) performance of 3.5%. Over the past year, the stock has seen a 1.13% change. These figures summarize STAA's price movements across various periods, reflecting its historical returns.
According to current financial data, STAA stock's P/E (TTM) ratio is -12.92, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for STAA, including P/S (5.39), P/B (3.52), and P/FCF (-31.43), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.